For most patients, a BMI of 30 or greater represents the primary qualification threshold for GLP-1 weight loss treatment
Whenever youre activating something in the brain, we can expect that the brain and the GI tract may respond with nausea. GLP-1 medications also work in the gut by slowing down the digestion process, so food is in the stomach for a longer period of time
They do not provide product-use, preparation, administration, dosing, injection, clinical or treatment guidance
Your prescription ships discreetly with supplies
FDA approval is anticipated for late this year or early next year
A study in The New England Journal of Medicine found that just 33% of the dose drove 72% of the weight loss at week 72 with a lower side effect profile